J&J To Build Capacity, Widen Access To Bedaquiline In India
Prevention In Spotlight At India Conference
J&J ties up with agencies, Indian government to build capacity and widen access to Sirturo for TB patients.
You may also be interested in...
Price cuts, new treatments for TB and alliances to improve access to these medicines were among the key talking points at the recently concluded Union World Conference on Lung Health in India. TB survivors and activists were also vocal and pressed hard for their demands to be heard.
The healthcare giant is investing heavily into partnerships designed to beat the two infectious diseases.
Significant leadership change is underway at J&J India, with Janssen India chief Sanjiv Navangul on his way out. He will be succeeded by senior J&J hand, Sarthak Ranade, who will need to handle some delicate issues pertaining to Sirturo while also keeping the flow of innovative products from the parent company to India going.